TAKING cue from the recommendation of the Food and Drug Administration (FDA), President Rodrigo Duterte is not taking chances on the COVID-19 vaccine developed by Sinovac Biotech.
He will wait instead for the emergency use authorization (EUA) to be issued to his preferred COVID-19 vaccine of biopharmaceutical firm Sinopharm.
Presidential spokesperson Harry Roque hinted at the President as willing to wait for a Sinopharm EUA before having himself injected.
The Palace’s legal team has earlier been reported as “studying whether the President can get his Sinopharm jab under a “compassionate use permit” issued by the FDA.
“Mag-aantay po siya ng EUA ng Sinopharm,” Roque told reporters, adding that Sinopharm has submitted an online application for an EUA before the FDA.
An emergency use authorization from the FDA is essential before anyone can be legally administered with a vaccine. Interestingly, the FDA has allowed the use of the vaccine without EUA approval months after members of the Presidential Security Group had themselves injected with smuggled Sinopharm vaccines.
But even with a compassionate use permit issued to Siniopharn, the Chinese biopharmaceutical firm would still be required to secure an approval from the FDA.